Advances in CT assessment of metabolic and endocrine disorders.
Advances in diagnostic imaging of endocrine disorders are occurring rapidly. In certain disease entities, such as Cushing's disease, pheochromocytoma, primary aldosteronism, and islet cell tumors, noninvasive imaging techniques like CT have become the initial diagnostic imaging procedures of choice. In other disorders, such as hyperparathyroidism, carcinoid, and thyroid disease, CT is making important contributions, and further advances can be anticipated.
D000307:Adrenal Gland Diseases / Q000000981:diagnostic imaging; D000311:Adrenal Glands / Q000000981:diagnostic imaging; D001851:Bone Diseases, Metabolic / Q000000981:diagnostic imaging*; D001842:Bone and Bones / Q000000981:diagnostic imaging; D004652:Empty Sella Syndrome / Q000000981:diagnostic imaging; D004700:Endocrine System Diseases / Q000000981:diagnostic imaging*; D006801:Humans; D006961:Hyperparathyroidism / Q000000981:diagnostic imaging; D010024:Osteoporosis / Q000000981:diagnostic imaging; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging; D010280:Parathyroid Glands / Q000000981:diagnostic imaging; D010900:Pituitary Diseases / Q000000981:diagnostic imaging; D010902:Pituitary Gland / Q000000981:diagnostic imaging; D014057:Tomography, X-Ray Computed